Sat, Aug 2, 2014, 1:34 AM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

BIOZONE PHARM Message Board

alliedmike 10 posts  |  Last Activity: Jul 25, 2014 2:43 PM Member since: Nov 13, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Someone knows something

    by alliedmike Jul 25, 2014 2:27 PM
    alliedmike@sbcglobal.net alliedmike Jul 25, 2014 2:43 PM Flag

    Agreed.. This is a turn around play that's still in the very early innings.

  • alliedmike@sbcglobal.net by alliedmike Jul 25, 2014 2:27 PM Flag

    Up 22% on 10X average volume and still and hour and a half left to trade. Something leaked

  • Reply to

    upgrade

    by alliedmike Jul 16, 2014 9:09 AM
    alliedmike@sbcglobal.net alliedmike Jul 16, 2014 9:33 AM Flag

    Localized current radiation therapy market is 300 million. I expect that number to grow in time as this type of therapy gets more widely recognized and known.

  • Reply to

    upgrade

    by alliedmike Jul 16, 2014 9:09 AM
    alliedmike@sbcglobal.net alliedmike Jul 16, 2014 9:16 AM Flag

    This story is still in it's infancy.. Maxim has been keeping a close eye with initiation in November of 2013 with a buy at $1.50.. Raised to $3.50, and now remains a buy with a target of $5.00. Coverage and support will continue to grow over time. Trade it if you want and save your pennies, but I'm sticking this one in my back pocket for the long haul. Follow the fundamentals, not the people here posting mindless junk.

  • alliedmike@sbcglobal.net by alliedmike Jul 16, 2014 9:09 AM Flag

    Maxim Group assumes coverage on IsoRay, Inc. (NYSE: ISR) with a Buy rating and a price target of $5.00 (from $3.50).

    Analyst Jason Kolbert said the rating is driven by their product model and the associated assumptions for market share penetration in prostate cancer, other cancers, and glioma across both products, Proxcelan and GliaSite RTS (w/ Cesitrex liquid Cs-131).

    "IsoRay announced the first implant brachytherapy seed (Proxcelan Cs-131) in brain cancer. Cesium-131 emits a high energy level for a short period of time. We find it to be superior to I-125 or Pd-103. Over time, we expect these attributes to drive a 20% market share penetration in the global radiation (localized therapy) $300M marketplace," Kolbert commented.

    He added, "We continue to be excited for the market share build--account by account and country by country--in both products (seeds and liquid) over the coming year as KOLs convert to Cs-131 based on its superior attributes."

  • Reply to

    I'm out...

    by alliedmike Jul 3, 2014 11:42 AM
    alliedmike@sbcglobal.net alliedmike Jul 3, 2014 4:29 PM Flag

    Hey, I hope it does go up for everyone else still holding. I just couldn't do it anymore. To keep the funds tied up in this as long as I have with no returns while sitting back and watching everything take off started to be too much. Yes, it was spec money, but still. I do like this company still, and if it starts to move, maybe I'll jump back in.. In the meantime I'm going to move the spec portain of my portfolio over ROX. Best of luck

  • alliedmike@sbcglobal.net by alliedmike Jul 3, 2014 11:42 AM Flag

    Sold my entire position this morning.. Just cant take it anymore. Solid company, but the stock and management pretty much sucks. A lot of good posters on this board, and I wish you all the very best both in life, and your investment decisions. Have a great fourth with your friends and families :)

  • alliedmike@sbcglobal.net by alliedmike Jun 12, 2014 12:40 PM Flag

    Any guesses what we got when we reopen?

  • Reply to

    Any minute now...

    by alliedmike May 6, 2014 10:57 AM
    alliedmike@sbcglobal.net alliedmike May 6, 2014 11:47 AM Flag

    ^^ and not in the good way that I like ^^

  • alliedmike@sbcglobal.net by alliedmike May 6, 2014 10:57 AM Flag

    We just might trade the first share of the day!!!!
    LOL I hate this stock :(

BZNE
0.410.00(0.00%)Apr 14 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Berkshire Hathaway Inc.
NYSEFri, Aug 1, 2014 4:02 PM EDT
Tesla Motors, Inc.
NasdaqGSFri, Aug 1, 2014 4:00 PM EDT